Flex Stock Down Post Q2 Earnings: Should You Buy, Hold or Offload?

Flex reported fiscal Q2 2027 adjusted EPS of $1.18, up 49.4% year over year and above the $1.05 consensus, while revenue rose 24.8% to $8.49 billion versus $8.18 billion expected; CPI revenue increased 54% to about $2.5 billion. Despite raising its fiscal 2027 outlook, shares fell about 7% after results and 25.9% over the past month. Supply constraints, fiscal 2027 capex of $1.5–$1.6 billion, lower free cash flow of $261 million and Axiom separation risks temper the outlook; the article recommends existing holders hold and new investors wait.

Analysis

The selloff appears less like a rejection of AI demand than a repricing of how much cash Flex must commit—and how much balance-sheet risk it carries—to convert that demand into earnings. The key second-order risk is that component scarcity and customer concentration can weaken the usual operating leverage: capacity is built ahead of delivery, inventory and capex absorb cash, and a delayed hyperscaler program can leave utilization below plan. Debt-funded expansion makes that cash-conversion gap more consequential ahead of the CPI separation.

The valuation case is less compelling than the article’s industry P/S comparison implies. A broad electronics-industry multiple is not a useful benchmark for a contract manufacturer; the cited Jabil and Sanmina multiples are much closer context and do not establish that Flex is unusually cheap. The market may be discounting capital intensity, financing costs and separation complexity rather than missing near-term revenue growth.

Near term, sentiment and execution risk can keep the shares volatile. Over the next 1–3 months, inventory, free-cash-flow conversion and any clarification of the Axiom transaction matter more than headline CPI growth. Over 6–18 months, successful capacity ramp and separation could support a rerating; customer deferrals, cost overruns or weaker cash conversion would undermine it. The thesis is falsified if subsequent results show inventory normalizing and cash generation recovering while growth holds—or, negatively, if guidance weakens or separation financing terms disappoint.

Key Decisions for Investors

• Avoid chasing the post-results dip; consider a small, staged long only after the next report confirms improving free-cash-flow conversion alongside continued CPI growth. Add only if inventory growth moderates and capex remains within the stated plan.
• For existing exposure, hold at a risk-sized position rather than treating the drawdown as proof of mispricing. Reassess if management cuts outlook, inventory continues to outgrow revenue, or debt/financing costs rise beyond expectations.
• Use the next quarterly update and Axiom transaction disclosures as catalysts: verify working-capital movement, segment margins, capex, debt costs, and separation expenses. Until then, no high-conviction pair trade is supported by the available data.
• Treat the broad industry P/S discount as a weak buy signal; compare Flex with contract-manufacturing peers and monitor whether cash flow, not just adjusted earnings, begins to validate the AI-driven investment cycle.